Literature DB >> 29637495

High-throughput genetic screens using CRISPR-Cas9 system.

Jiyeon Kweon1, Yongsub Kim2.   

Abstract

The CRISPR-Cas9 system is a powerful tool for genome engineering, and its programmability and simplicity have enabled various types of gene manipulation such as gene disruption and transcriptional and epigenetic perturbation. Particularly, CRISPR-based pooled libraries facilitate high-throughput screening for functional regulatory elements in the human genome. In this review, we describe recent advances in CRISPR-Cas9 technology and its use in high-throughput genetic screening. We also discuss its potential for drug target discovery and current challenges of this technique in biomedical research.

Entities:  

Keywords:  CRISPR–Cas9 system; Genome engineering; High-throughput screening; Pooled CRISPR screens

Mesh:

Year:  2018        PMID: 29637495     DOI: 10.1007/s12272-018-1029-z

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors.

Authors:  Laura M Rogers; Zhaoming Wang; Sarah L Mott; Adam J Dupuy; George J Weiner
Journal:  Cancer Immunol Res       Date:  2020-07-01       Impact factor: 11.151

Review 2.  Synthetic Vulnerabilities in the KRAS Pathway.

Authors:  Marta Roman; Elizabeth Hwang; E Alejandro Sweet-Cordero
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

Review 3.  Acceleration of cancer science with genome editing and related technologies.

Authors:  Tetsushi Sakuma; Takashi Yamamoto
Journal:  Cancer Sci       Date:  2018-10-31       Impact factor: 6.716

4.  High-content imaging-based pooled CRISPR screens in mammalian cells.

Authors:  Xiaowei Yan; Nico Stuurman; Susana A Ribeiro; Marvin E Tanenbaum; Max A Horlbeck; Christina R Liem; Marco Jost; Jonathan S Weissman; Ronald D Vale
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

5.  A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.

Authors:  Yosi Gilad; Yossi Eliaz; Yang Yu; Adam M Dean; San Jung Han; Li Qin; Bert W O'Malley; David M Lonard
Journal:  Commun Biol       Date:  2021-03-25

Review 6.  CRISPR Screening: Molecular Tools for Studying Virus-Host Interactions.

Authors:  Vladimir Chulanov; Anastasiya Kostyusheva; Sergey Brezgin; Natalia Ponomareva; Vladimir Gegechkori; Elena Volchkova; Nikolay Pimenov; Dmitry Kostyushev
Journal:  Viruses       Date:  2021-11-11       Impact factor: 5.048

7.  CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells.

Authors:  Lin Shen; Chao Li; Fang Chen; Liangfang Shen; Zhanzhan Li; Na Li
Journal:  Cell Death Discov       Date:  2021-12-14

8.  C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9.

Authors:  Saskia-Larissa Jauch-Speer; Marisol Herrera-Rivero; Nadine Ludwig; Bruna Caroline Véras De Carvalho; Leonie Martens; Jonas Wolf; Achmet Imam Chasan; Anika Witten; Birgit Markus; Bernhard Schieffer; Thomas Vogl; Jan Rossaint; Monika Stoll; Johannes Roth; Olesja Fehler
Journal:  Elife       Date:  2022-05-11       Impact factor: 8.713

9.  Swift Large-scale Examination of Directed Genome Editing.

Authors:  Omar T Hammouda; Frank Böttger; Joachim Wittbrodt; Thomas Thumberger
Journal:  PLoS One       Date:  2019-03-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.